about
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobron...
Read More
1.88
0.05
(2.73%)
118.2K
XNAS Volume
XNAS 05 Oct, 2026 12:46 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Pulmonx Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..